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Abstract RNA is a key molecule in life, and compre-
hending its structure/function relationships is a crucial step
towards a more complete understanding of molecular
biology. Even though most of the information required for
their correct folding is contained in their primary sequen-
ces, we are as yet unable to accurately predict both the
folding pathways and active tertiary structures of RNA
species. Ribozymes are interesting molecules to study
when addressing these questions because any modiﬁcations
in their structures are often reﬂected in their catalytic
properties. The recent progress in the study of the struc-
tures, the folding pathways and the modulation of the small
ribozymes derived from natural, self-cleaving, RNA motifs
have signiﬁcantly contributed to today’s knowledge in the
ﬁeld.
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Introduction
RNA is a key molecule in life, and the understanding of its
structure/function relationships is crucial in molecular
biology and therefore has important implications in terms
of human health [1]. However, we are as yet unable to
accurately predict either the folding pathway or the active
tertiary structure of RNA molecules from their primary
sequences. Clearly, these two fundamental questions need
to be addressed. A long-term goal is to be able to interpret
an RNA sequence in terms of its functionally folded three-
dimensional form. RNA molecules possess a hierarchical
structure: the primary sequence determines the formation
of the secondary structure elements, and the secondary
structure in turn determines the tertiary folding [2–4]. RNA
molecules fold sequentially from 50 to 30 using recurring
stable submotifs [5, 6], and the folding intermediates tend
to become increasingly stable as the tertiary interaction
network progresses [7–9]. RNA can fold into multiple
structures; however, only a single structure is usually
functional. In order to fold correctly, the RNA must avoid
the problem of folding into alternative, non-functional
structures and kinetic traps [10–13].
Ribozymes are interesting molecules to study when
addressing these RNA questions because modiﬁcations in
their structures are reﬂected in their catalytic properties.
More precisely, small ribozymes are suitable for this task
since considerable progress has been made in the deter-
mination of their structures [14, 15], and a versatile toolbox
is available for their study. Here we present a review of the
recent progress in the study of the tertiary structures, the
folding pathways and the modulation of the small ribo-
zymes derived from natural, self-cleaving, RNA motifs.
Small self-cleaving ribozymes
This group of natural ribozymes includes ﬁve RNA species
that have been derived from self-cleaving sequences
ranging from *40 to 200 nucleotides in length and pos-
sessing various secondary structures. One subgroup
includes three self-catalytic RNA motifs that are part of
species belonging to the brotherhood of small, circular,
self-replicating RNAs and are essential components of the
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RNAs. According to this mechanism, the circular monomer
strands are replicated into linear multimeric strands of
complementary polarity that then are self-cleaved, on the
basis of the RNA motifs, into monomers that, following
circularization, participate in the next round of replication
[16]. More speciﬁcally, the hammerhead and hairpin RNA
motifs were obtained from viroids and viroid-like satellite
RNAs of plant origin [17–22], while the HDV self-cleaving
RNA motif was obtained from the hepatitis delta virus
(HDV) that infects humans [23–25]. The hammerhead
motif has also been detected in eukaryote satellite DNA
transcripts obtained from newt, schistosome and cricket
[26–28], while the HDV motif has also been detected in the
human genome [29].
The members of the second subgroup of natural self-
cleaving RNA motifs are found within the bodies of larger
transcripts. For example, the VS self-cleaving motif was
identiﬁed by accident in the Varkud satellite RNA, an
abundant transcript from the circular mitochondrial Varkud
satellite DNA found in numerous Neurospora species and
in other simple eukaryotes [30]. In common with the above
ribozymes, this self-catalytic motif, in vivo, processes a
multimeric RNA into monomers [31]. Another example is
the glmS self-cleaving motif that was identiﬁed, by com-
puter analysis of the 50 untranslated region (50UTR) of the
glucosamine-6-phosphate synthase (glmS) mRNA of cer-
tain gram-positive bacteria, to be a putative riboswitch
[32]. In fact, upon the binding of glucosamine-6-phosphate
(GlcN6P), the glmS motif has been shown to undergo a
site-speciﬁc self-cleavage reaction making it the ﬁrst, and
as yet the only, natural allosteric ribozyme [33]. This
cleavage dramatically decreases the half-life of glmS
mRNA, and thus this ribozyme acts as a regulatory element
controlling the glucosamine-6-phosphate synthase level
[33].
All of these self-cleaving RNA motifs catalyze the
cleavage of the RNA phosphodiester backbone through a
transesteriﬁcation reaction involving the attack of the vic-
inal 20-hydroxyl group (20-OH) on the scissile phosphate,
yielding a 20-30-cyclic phosphate and a 50-hydroxyl termini
as products [34]. The mechanism involved is a bimolecular
nucleophilic substitution (SN2) that is general acid–base
catalyzed and requires in-line geometry between the 20
oxygen, the phosphate and the 50 oxygen. The catalytic
strategies and active site organization at the atomic level
for each of these ribozymes have been extensively char-
acterized and do not fall under the scope of this work since
these aspects have been recently been reviewed [1, 15].
Finally, the presence of divalent metal cations is important
in RNA folding in order to obtain well-deﬁned structures,
as well as in the catalysis, by functioning either as a general
acid or as a general base when coordinated with water.
These self-cleaving RNA motifs are metalloenzymes under
physiological conditions, but are also active in the absence
of divalent metals under certain conditions such as in the
presence of high monovalent metal ion concentrations or at
low pH levels [35, 36].
HDV ribozyme
The self-cleaving RNA motif derived from HDV varies
from 85 to 95 nucleotides in length depending on the
sequence variant and the polarity. It has been possible to
separate this self-catalytic sequence into two molecules,
thereby creating a trans-acting system where one molecule,
the ribozyme, possesses the catalytic properties required to
cleave multiple copies of the other molecule, the substrate.
This separation can be achieved in several ways, the most
frequent being the removal of the junction between stems I
and II (Fig. 1a) [25]. The development of trans-acting
ribozymes, for HDV as well as all other self-catalytic RNA
motifs, has permitted experiments leading to the identiﬁ-
cation of the important structural features of these motifs
[24, 25, 37]. For example, direct mutagenesis experiments
led to the identiﬁcation of the crucial nucleotides in the
catalytic core, as well as identifying essential base-paired
positions [for examples see Refs. 37, 38]. It should be
noted, however, that an unbiased in vitro selection revealed
that, with the exception of the catalytic nucleotide (position
76), none of the bases were absolutely required for cleav-
age [39]. This work clearly revealed that the ribozyme
supports more variability than was originally thought to be
the case based on the isolation of natural sequences. In
addition, it also revealed that higher cleavage levels were
observed for sequences closely related to the natural ones,
suggesting that the combination of all of the structural
features is important for optimal cleavage activity.
According to the experimentally well-supported
pseudoknot model, the HDV ribozyme is composed of one
stem (I or P1), one pseudoknot (II or P2), two stem-loops
(stems III or P3 and IV or P4) and three single-stranded
junctions (I/II, I/IV and IV/II). The structure depicted in
Fig. 1a is derived from the HDV of antigenomic polarity.
Previous nomenclature of the various regions and the
harmonized one using roman numbers for the stems are
indicated. It is composed of a 57-nucleotide ribozyme and
an 11-nucleotide substrate. By using this design, the stem I
is composed of one Wobble base pair followed by six
Watson–Crick base pairs formed between the ribozyme
and the substrate and becomes the recognition domain.
Both the junction I/IV and the loop III are single-stranded
in the initial folding steps, but are eventually involved in
the formation of a second pseudoknot (I.I) [37, 40, 41].
This structure requires the presence of divalent cations
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Both X-ray diffraction analysis and nuclear magnetic
resonance studies have provided high-resolution tertiary
structures of the genomic HDV ribozyme [40, 43, 44].
Overall, these approaches have shown that the global shape
of the ribozyme is dominated by two coaxial helices
formed by the stacking of the stems I–I.I–IV and the stems
II–III (Fig. 1b). The stems II and IV have a structural role
and are located above and below the catalytic core, which
is formed by a network of interactions located at the
interface between the two helical stacks. This network
relies heavily on the nucleotides’ identities, as well as on
several of the 20-OH groups of the ribose moieties [38, 45].
The crystal structure of the genomic HDV ribozyme also
revealed that this catalytic RNA adopts a highly ordered
structure [40, 43, 46], in agreement with the previously
reported unusual properties of this motif. For example, the
self-catalytic motif retains activity at temperatures as high
as 80C and in solutions containing up to 5 M urea [47,
48]. Moreover, it was shown that for some trans-acting
HDV ribozyme variants the cleavage level was near 100%,
suggesting that HDV ribozyme forms a homogeneous
population of structures and is not prone to alternative
structure formation [8]. This important characteristic has
been fully exploited in order to decipher the folding path-
way of the HDV ribozyme, by far the most complex
folding pathway elucidated to date for a small ribozyme.
Extensive work has been performed using a number of
approaches, including in vitro selection and photo-induced
cross linking, in order to identify a speciﬁc set of mutants
able to halt the folding pathway at each stable intermediate
[39, 49]. Brieﬂy, after the recognition of the substrate by
the ribozyme leading to the formation of the stem I, ﬁve
subsequent conformational steps are required in order to
form the catalytically active structure (Fig. 1c). The ﬁrst
conformational transition is the docking of the stem I
within the catalytic core. A speciﬁc interaction between the
substrate in the middle of the stem I, which is slightly
unfolded at the position ?4 from the cleavage site, and
both the C22 and the U23 residues of the loop III are most
likely responsible for this docking [50]. This conclusion is
supported by the fact that replacing a weak base pair, such
as UA, in the middle of the stem I by a stronger base pair,
such as GC, is detrimental to the ribozyme’s activity [51].
The substitution of an A for a U in position 23 blocks stem
I docking to the catalytic core [50]. The second confor-
mational transition is the formation of the pseudoknot I.I,
which includes two GC base pairs [37, 41]. Any mutation
of the pseudoknot I.I reducing either its stability, or the
coaxial stacking, is detrimental to the cleavage activity
[52]. The third conformational step is the formation of the
A-minor motif between the two consecutive adenosines of
the junction IV/II and the minor groove of the stem III,
more speciﬁcally with the two GC base pairs of the latter
[40]. This is a key interaction for the positioning of the
junction IV/II, which is otherwise quite ﬂexible. Moreover,
this conformational transition initiates the positioning of
the catalytic cytosine (C76), which is also located within
the junction IV/II. The replacement of the adenosines in
positions 78 and 79 by uridines prevents any further pro-
gression along the folding pathway [8, 40]. The fourth and
ﬁfth conformational steps are the formation of the trefoil
motif and a base pair switch at the bottom of the stem II,
respectively [40, 53, 54]. These two steps most likely occur
simultaneously, although an order has been suggested
based on physico-chemical analyses [8]. The trefoil turn is
a particular motif identiﬁed by X-ray crystallography
involving the catalytically active cytosine and its two
ﬂanking nucleotides [40]. This motif is induced by the
formation of the A-minor motif and is proposed to con-
tribute relaxing the phosphodiester backbone of the
junction IV/II, thereby positioning the cytosine deep inside
the catalytic centre [54]. Altering the trefoil turn motif by
deleting the uridine in position 77 results in a ribozyme
completely deprived of catalytic activity [53]. The other
conformation transition, the base pair switch, takes place
at the bottom of the stem II. It consists of switching the
Fig. 1 Structure and folding pathway of HDV ribozyme. The
ribozyme and substrate are denoted by Rz and S, respectively. The
cleavage site is indicated by an arrow. a Secondary structure of a
shortened trans-acting version of the wild-type antigenomic HDV
ribozyme according to the notation of Leontis and Westhof [145]. The
harmonized nomenclature using roman numbering for the stems is
indicated as well as the previous one in parenthesis. The dotted line
represents the junction that has been removed in order to generate a
trans-acting version. b Crystal structure of the genomic version of
HDV ribozyme [46]. The colors of the various domains are the same
in both panels A and B. c Proposed folding pathway of HDV
ribozyme according to Reymond et al. [8]. The substrate is shown in
green and the products in red. Important nucleotides are indicated in
the various intermediates
Folding of small ribozymes 3939C19–G81 base pair of the stem II to a new C19–G80 base
pair and also bulging out the G81 residue [53]. The
replacement of the guanosine in position 80 by a cytosine
prevents the adoption of the ribozyme–substrate transition
complex. This base pair switch is also induced by the
formation of the A-minor motif. Upon completion of the
base pair switch, the geometry at the catalytic site is cor-
rect, and the chemical reaction occurs. The nucleotide
involved in this chemical step is the catalytically active
cytosine C76, which plays the role of a general base [55,
56]. Any mutation of this cytosine results in the complete
loss of cleavage activity. When the transesteriﬁcation
reaction occurs, it is simultaneously accompanied by the
products’ release. However, under certain conditions, it has
been shown that the 30-product might remain associated
with the ribozyme, thereby causing product inhibition.
In summary, each of these conformational steps is sep-
arated by the formation of speciﬁc interactions. Several
mutants have been designed in order to block the folding
pathway at stable intermediates by disrupting these inter-
actions. These mutants have been used in an isothermal
titration calorimetry study that yielded the complete ther-
modynamic characterization of the HDV folding pathway
[8]. This folding pathway is enthalpy driven, and the for-
mation of additional interactions, such as the stacking in
the coaxial helices, is responsible for the stability of this
complex structure. The formation of the pseudoknot I.I has
been shown to be the limiting step in the molecular
mechanism of the HDV ribozyme [8, 46]. At the beginning
of the folding pathway, the loop III and junction I/IV are
located relatively far from each other and have a signiﬁcant
amount of freedom. The formation of the pseudoknot I.I is
required in order to bring together these two single-stran-
ded regions, thereby trapping the substrate within the
catalytic core [49]. This requires an important entropic
loss, and the driving force of this step is most likely the
formation of two GC base pairs and the coaxial stacking of
the helices I–I.I–IV.
Three different strategies have been used to modify
activity of the HDV ribozyme. The ﬁrst one is based on the
fact that, due to its self-cleaving origin, the HDV ribozyme
suffers from a lack of substrate speciﬁcity when used in
trans as a molecular tool. Its substrate speciﬁcity depends
on the formation of stem I that contains only seven base
pairs (Fig. 1a), while a total of 15–16 base pairs has been
estimated to be required in order to ensure the targeting of
a unique RNA species from the human transcriptome [57].
This is the reason why the past interest in this ribozyme
was only moderate. In order to overcome this hurdle a
module named the SOFA (Speciﬁc On/ofF Adaptor) was
engineered for the HDV ribozyme (Fig. 2a) [58]. The
SOFA adaptor switches the cleavage activity from ‘‘off’’ to
‘‘on’’ state solely in the presence of its cognate substrate.
This modulation acts at two different levels. The substrate
binding site forms a short duplex with an inserted sequence
element (the blocker); this increases the energetic barrier
for non-speciﬁc base-pairing interactions with the substrate
binding site, thus reducing the potential for off-target
cleavages. A second inserted sequence element (the bio-
sensor) extends base-pairing with the substrate to favor
binding of the genuine substrate, and formation of this
duplex concomitantly results in disruption of the short
duplex involving the blocker sequence. Analysis of the
cleavage activity using a large collection of substrates and
Fig. 2 Various modulated versions of the HDV ribozyme. The
inactive and active states are indicated by ‘‘off’’ and ‘‘on’’, respec-
tively. The substrate is shown in green, and the portion of the
ribozyme responsible for the modulation in blue. a The SOFA module
[58]. BL and BS indicate blocker and biosensor, respectively. b The
G-quartzyme [64]. c The theophylline aptamer attached by a
communication module [65]
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of each domain and gave hints for design optimization
[59]. The proof-of-concept of this adaptor was demon-
strated both in vitro and in vivo using several SOFA-
ribozymes that cleaved various RNA transcripts [58, 60,
61]. Several alternative versions of the SOFA module have
been reported for the HDV ribozyme, and it has been
adapted to various ribozymes including both the hammer-
head and the hairpin ribozymes [62].
Two other ways by which the HDV ribozyme’s activity
can be modiﬁed involve the use of allosteric modules
adapted to the HDV ribozyme. The ﬁrst involves using an
aptamer known to fold into an unstable hairpin structure in
the absence of potassium and into a G-quadruplex structure
upon the addition of potassium [63]. A rationally designed
HDV ribozyme in which most of the stem II was replaced
by this aptamer lost its cleavage activity in the absence of
potassium (Fig. 2b) [64]. Further structural characteriza-
tion led to the proposal that the 50-strand of the aptamer
was interacting with loop III, inactivating the HDV ribo-
zyme. The addition of potassium promotes the formation of
the G-quadruplex structure involving both strands of the
aptamer, releasing the catalytic core of the ribozyme and
stabilizing it by the formation of the stem II. The resulting
RNA species represents a new class of ribozyme that
exhibits a monovalent cation-dependent activity. The sec-
ond method involves replacing most of the stem IV by a
randomized region followed by a theophylline aptamer
previously developed by in vitro selection (Fig. 2c) [65].
A negative selection was performed so as to remove all
the sequences that cleave in the absence of theophylline.
A positive selection was then performed in order to enrich
the pool of sequences that are active in the presence of
theophylline, thereby selecting a theophylline-dependent
allosteric HDV ribozyme.
Hammerhead ribozyme
The hammerhead ribozyme is undoubtedly the most stud-
ied catalytic RNA so far. It was the ﬁrst to be discovered
[18, 66] and to have its crystal structure determined [67,
68]. It is famous for the dilemma surrounding the poor
correlation that exists between the biochemical data and the
crystal structures of minimal versions [69–71]. The ham-
merhead ribozyme adopts a ‘‘Y-shape’’ consisting of three
helical stems of variable sequence and length named stems
I–III (Fig. 3a). In the center of the three-way junction of
the Y, 11 highly conserved nucleotides form the catalytic
core that includes the cleavage site located 30 of an
important single-stranded cytosine residue [17]. A recent
X-ray crystal structure of a larger version derived from
Schistosoma mansoni underlines the importance of two
peripheral elements, speciﬁcally a hairpin loop located at
the end of stem II and a bulge located in the longer stem I
(Fig. 3b) [72]. Interaction of these two motifs in a tertiary
manner increases the cleavage rate by at least 50-fold [73].
Most, if not all, natural hammerhead self-cleaving motifs
appear to contain similar interactions between loops or
bulges located in stems I and II [74, 75]. Moreover, this
new crystal structure reconciled older chemical data and
provided a basis to hypothesize how the transition state
might be achieved [76]. In this transition state an interac-
tion network implicating key nucleotides (G8, A9, G12,
U16.1 and C17) positions the 20-hydroxyl nucleophile, the
scissile phosphate and the 50-oxygen leaving group at an
angle very close to 180 [72].
Trans-acting hammerhead ribozymes have been exten-
sively used to develop gene-inactivation systems either for
functional genomic applications or for therapeutic aims
[77, 78]. Several trans-acting versions have been produced
by cleaving the RNA strand at various locations within the
Fig. 3 Structure and folding pathway of the hammerhead ribozyme.
The ribozyme and substrate are denoted by Rz and S, respectively.
The cleavage site is indicated by an arrow. a Secondary structure of a
trans-acting version of the hammerhead ribozyme [72] according to
the notation of Leontis and Westhof [145]. The corresponding
minimal version is obtained by removing the shaded region at the top.
The tertiary interactions between the loop of stem II and the bulge of
stem I are illustrated by the thin curved lines. b Crystal structure of
the Schistosome version of hammerhead ribozyme [72]. The colors
of the various domains are the same in panels A and B. c Hammerhead
ribozyme’s folding pathway. The substrate is shown in green, and the
products in red
Folding of small ribozymes 3941loops, with the most common involving strand breaks in
loops I and III. In such trans-acting versions, the initial step
of the folding pathway is the formation of the ribozyme–
substrate complex via assembly of both stems I and III.
Then the tertiary interaction network is established, which
enables formation of the transition state for cleavage
(Fig. 3c). Depending on the length and the base composi-
tion of the stems formed between the substrate and the
ribozyme, product release inhibition has been observed.
The hammerhead ribozyme is also by far the most
studied RNA molecule in terms of the modulation of the
catalytic activity, either directly or by the addition of
motifs leading to the production of allosteric versions.
Several compounds were reported to either positively or
negatively modulate the hammerhead cleavage activity
[79–81]. For example, in the case of antibiotics, usually
inhibitory effects were observed. This is nicely exempliﬁed
by the effect of neomycin on hammerhead activity [79]. In
this case, it has been proposed that neomycin interacts
directly with the ribozyme–substrate complex, stabilizing
the ground state over the transition state and thereby
inhibiting cleavage. Other antibiotics, such as chlorotetra-
cycline, either stimulate or inhibit depending on the
reaction conditions [80]. However, in general the mecha-
nisms by which antibiotics affect the cleavage activity
remain elusive [79]. Another interesting mechanism has
been reported in a study of metal ion inhibition of the
hammerhead cleavage. For example, terbium ions tightly
bind to the ribozyme and subsequently displace an adjacent
magnesium cation important for the catalytic activity [82].
In the case of cobalt hexammine, a study revealed that it
binds to the hammerhead ribozyme and provokes a con-
formational change that produces an inactive structure [83].
Finally, several proteins and peptides with RNA chaperone
activities have been shown to positively modulate ham-
merhead ribozyme activity [84–89]. For example, the p7
nucleocapsid protein of HIV has been demonstrated to
resolve misfolded ribozyme–substrate complexes [84].
Other proteins, such as hnRNP A1, enhance the binding
rate of the substrate and signiﬁcantly accelerate product
release, thereby increasing ribozyme turnover [85].
Since Watson–Crick base pairs are predictable, several
strategies directed towards controlling hammerhead activ-
ity were based on the use of either additional sequences or
complementary oligonucleotides. For example, in the case
of modulation through additional sequences, the SOFA
module developed for the HDV ribozyme was adapted to
the hammerhead ribozyme [62] (Fig. 4a). The blocker was
inserted at the 50 end of stem I and interacts with the 30 arm
of stem III, thereby blocking the ribozyme in an ‘‘off’’
state. The biosensor complementary to the 50 region of the
substrate was added to the 30 end of stem III. Substrate
annealing to the biosensor then promotes the displacement
of the blocker, yielding a ribozyme in an ‘‘on’’ state. In
the case of modulation through complementary oligonu-
cleotides, facilitator oligonucleotides that interact with
regions of the substrate outside of the binding site of the
ribozyme were shown to modify the ribozyme’s kinetic
parameters. Positive effects are seen when the facilitator
binds the substrate 30 of the ribozyme, while negative ones
are observed when it binds 50 of the ribozyme [90].
Alternatively, other strategies involving trans-acting
oligonucleotides that interact with the ribozyme were
designed in order to modulate the cleavage activity
(Fig. 4b–d) [91–94].
Fig. 4 Various modulation strategies for the hammerhead ribozyme
based on complementary sequences. The inactive and active states are
indicated by ‘‘off’’ and ‘‘on’’, respectively. The substrate is shown in
green and the portion of the ribozyme responsible for the modulation
in blue. The trans-acting oligonucleotides are represented by the
dotted lines. a The SOFA module [62]. BL and BS indicate blocker
and biosensor, respectively. b Three-strand ribozyme strategy [91].
c Blocker release strategy [93]. d Stem II stabilization strategy [92]
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strategies have been used for the development of a wide
repertoire of allosteric hammerhead ribozymes (also named
aptazymes). The ribozyme activity is switched from inac-
tive to active, or vice versa, by the binding of an effector
to an adjacent aptamer domain (Table 1, upper portion)
[95–106]. The general strategy involves using aptamers
previously reported to be speciﬁc for a compound and then
inserting them in one of the structural stems of the
hammerhead ribozyme. Insertion in either stem I or III
generally regulates the substrate binding step, while
insertion in stem II usually either impairs the formation or
decreases the stability of this helical region critical for the
catalytic activity. Aptamers can be speciﬁc to various small
components and proteins, including adenosine-50-triphos-
phate (ATP), theophylline, ﬂavin mononucleotide (FMN)
and the HIV Tat protein, to name only a few examples, and
have been reported to regulate hammerhead catalytic
activity [95–100, 104]. Interestingly, two allosteric
ribozymes using the insertion of the same ATP aptamer
within stem II have been demonstrated to regulate the
catalysis in different ways [95, 96]. The only difference
between the two was in the linker domain located between
the aptamer domain and the catalytic core. In one construct
this communication module is composed of 4 base pairs
that form a proper stem II in the absence of ATP, leading to
negative modulation [95, 96]. In the second construct, the
presence of a linker composed of 14 bases including only 3
base pairs prevents the formation of stem II and yields an
inactive ribozyme in the absence of ATP, leading to
positive modulation [95]. Clearly, this illustrates the
importance of the communication module in the allosteric
behavior of a ribozyme. Moreover, cooperativity between
the binding of two different effectors has also been
reported [100]. In this case, FMN and theophylline apta-
mers have been juxtaposed within stem II and sequential
binding of both effectors is required in order to activate the
ribozyme.
Table 1 Allosteric hammerhead ribozymes
Effector Modulation Region Mechanism Ref.
Allosteric hammerhead ribozymes developed by rational design
ATP _ Stem II Steric interference between bound
aptamer and HHRz tertiary
structure
[96]
FMN ? Stem II Stabilization of stem II [97]
ATP and FMN ? Stem III Control the accessibility/formation of
the substrate binding site
[99]
ATP and theophylline ± Stem II Stabilization or disruption of stem II [95]
FMN and theophylline ? Stem II Stabilization of stem II [98]
FMN and theophylline ? Stem II Stabilization of stem II [100]
Theophylline, tetracycline and xanthine ± Stem II In vivo RNA-based gene-regulatory
platform
[106]
TMPyP4 ± Stem II Stabilization of stem II [101]
Light and caged theophylline ? Stem II Stabilization of stem II [105]
ERK2 phosphorylated or unphosphorylated ? Stem II Stabilization of stem II [102]
HCV helicase/replicase ? Stems I, II, III and I,III Increase the afﬁnity of the HHRz for
its substrate
[103]
Tat protein ± Stem II Stabilization of stem II or slip-
structure mechanism
[104]
Allosteric hammerhead ribozymes developed by in vitro selection
Oligonucleotides ? Stem II Reorganization and stabilization of
stem II
[114]
cAMP, cCMP and cGMP ? Stem II Slip-structure mechanism [107][ 108]
FMN, theophylline and ATP ± Stem II Slip-structure mechanism [113]
Theophylline and 3-methylxanthine ? Stem II The level of modulation depend on the
communication module selected
[110]
Caffeine and aspartame ? Stem II n.d. [109]
Mn
2?,F e
2?,C o
2?,N i
2?,Z n
2? and Cd
2? ? Stem II Stabilization of stem II [112]
Light and (BDHP-COOH or BCPD-COOH) ? Stem II Stabilization of stem II [111]
n.d. Not determined
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isolated by in vitro selection (see Table 1, lower portion)
[107–114]. Generally, in terms of allosteric ribozymes, the
initial rounds are performed using a negative selection
process that removes the sequences that do not require the
presence of the effector for cleavage to occur, followed by
subsequent rounds using a positive selection in the pres-
ence of the effector. For most of the reported allosteric
hammerhead ribozymes, the region including the ran-
domized positions was introduced in stem II. In vitro
selection yielded allosteric domains that exhibit a very
high level of speciﬁcity for their effectors, even discrim-
inating between closely related compounds such as
cAMP, cCMP and cGMP [107, 108]. Alternatively, the
reselection of an allosteric hammerhead ribozyme with an
improved discrimination power for a given effector after
mutagenesis of the original aptamer domain has also been
reported [110]. This type of strategy has been used to
isolate ribozymes whose activities are modulated by
photosensitive compounds [105, 111], opening the way to
in vivo light-regulated gene expression through the
activity of photochemically modulated hammerhead
ribozymes.
Finally, as is the case with the rational design of allo-
steric ribozymes, the domain linking the aptamer and the
catalytic core is very important, in terms of the modula-
tion, for in vitro selected allosteric ribozymes. In vitro
selection of a communication module connected to an
FMN-aptamer has shown that in some cases the effector
causes a positive modulation, while for other sequence
variants it causes a negative regulation [113]. In a
similar study, several theophylline-dependent allosteric
hammerhead ribozymes harboring various sequences as
communication sequences have been isolated, illustrating
the ﬂexibility of this domain [110]. Furthermore, a com-
munication module is not restricted to one speciﬁc
aptamer or particular ribozyme. The same activating
communication module selected for the FMN aptamer was
used in a construction with both an ATP aptamer and a
theophylline aptamer, causing a positive modulation of the
activity in the presence of the ligand. In the same way, a
communication module selected with the HDV ribozyme
was also effective when transferred into a hammerhead
ribozyme [65]. Clearly, the communication module is a
key feature of allostreric ribozymes, permitting the trans-
fer of properties from the aptamer domain to the catalytic
core. The molecular mechanism leading to the modulation
of in vitro selected hammerhead ribozymes remains lar-
gely unknown, mainly because the efforts to elucidate the
structures of both the inactive and active conformation
were limited. In many cases, the stabilization of stem II
has been proposed to be required for the adoption of a
catalytically active structure.
Hairpin ribozyme
In its naturally occurring form, the hairpin ribozyme adopts
a four-way junction secondary structure [115, 116]. Both
two-way and four-way junction trans-acting ribozymes
have been derived and extensively studied (Fig. 5a)
[117–119]. In the minimal two-way junction version, the
49-nucleotide-long ribozyme is composed of four helices
separated into two domains (A and B). Domain A com-
prises stems I and II (or H1 and H2) and an internal loop of
eight nucleotides, while domain B comprises stems III and
IV (or H3 and H4) and an internal loop of 16 nucleotides.
These two domains dock into a non-coaxial orientation,
and the interactions between the two internal loops form
the catalytic core of the ribozyme (Fig. 5b) [120]. This
catalytic core can be formed with a variety of domain-
connecting setups; in fact, it can even be formed if the two
domains are separated into two distinct RNA molecules
[121, 122]. The cleavage site and almost all of the con-
served nucleotides are located in these two internal loops
Fig. 5 Structure and folding pathway of the hairpin ribozyme. The
ribozyme and substrate are denoted by Rz and S, respectively. The
cleavage site is indicated by an arrow. a Secondary structure of a
four-way junction trans-acting version of the hairpin ribozyme [116]
according to the notation of Leontis and Westhof [145]. The
corresponding minimal two-way version is obtained by removing
the shaded region at the top. The tertiary interactions between the
internal loops A and B are illustrated by the thin curved lines. The
harmonized nomenclature using roman numbers for the stems is
indicated as well as the previous one in parenthesis. b Crystal
structure of the four-way junction version [116]). The colors of the
various domains are the same in panels A and B. c Hairpin ribozyme’s
folding pathway. The substrate is shown in green and the products in
red
3944 C. Reymond et al.[123]. The presence of a guanosine 30 of the cleavage site is
absolutely required as it is involved in stacking tertiary
interactions within the internal loop of domain B, being a
key feature of the hairpin catalytic core [124]. In contrast, a
variety of mutations can be found in the base-paired
regions as long as they support helix formation, the only
requirement being the presence of a guanosine as the ﬁrst
nucleotide in the ribozyme strand of stem II [125].
Folding of the hairpin ribozyme is a two-step folding
pathway: after the binding of the substrate that results in
the formation of domain A, the docking of the two internal
loops caused by tertiary interactions forms the catalytic site
(Fig. 5c). Once it is formed, the chemical step can then
occur using in-line geometry. Interestingly, the ligation
reaction is around tenfold more efﬁcient than the cleavage
reaction [126]. The hypothesis to explain this observation
is that the docking of the two internal loops confers sufﬁ-
cient rigidity to the catalytic core that the optimal geometry
is maintained and the highly reactive 20–30-cyclic phos-
phate can open and react with the 50-hydroxyl [126].
At least four different ways of modulating the activity of
the hairpin ribozyme have been succesfully used. First, in
vitro selected adenine-dependent hairpin ribozymes have
been developed; those require the metabolite adenine as a
structural component to be able to form their catalytic
cores (Fig. 6a) [127]. Second, the replacement of the short
stem IV with a communicator module has permitted the
introduction of a redox active aptamer into the ribozyme
resulting in allosteric regulation of the ribozyme’s activity
(Fig. 6b) [128]. Third, a SOFA version was developed in
which a short blocker sequence forming a stem II equiva-
lent was attached to the 30end of the ribozyme, and a
biosensor recognition sequence that is able to bind the
substrate was added to the 50end (Fig. 6c) [62]. As with the
hammerhead ribozyme, the binding of the substrate to
the biosensor allows the substrate to unfold the blocker and
bind in its place, thereby increasing the speciﬁcity of the
reaction. Finally, a modulation based on the presence of a
trans-acting oligonucleotide has been achieved by intro-
ducing a short stem loop between stems II and III. When an
oligonucleotide composed of either DNA or RNA com-
plementary to this new stem loop is bound, domains A and
B can no longer interact together and the catalytic activity
is disrupted (Fig. 6d) [129, 130].
VS ribozyme
With a length of around 140 nucleotides in its trans-acting
version, the VS ribozyme is the largest known small self-
cleaving ribozyme. Its crystal structure has not yet been
solved, although a recent small-angle X-ray scattering
study gave a low-resolution structure, which was used to ﬁt
the ribozyme and to conﬁrm its predicted overall shape
[131]. The secondary structure of this ribozyme is formed
by 5 helices, numbered from II to VI, that form two three-
way junctions sharing stem III (Fig. 7a). The substrate is
composed of stem I and, in contrast to other ribozymes, the
VS ribozyme is able to rely exclusively on tertiary inter-
actions in order to recognize its substrate [132]. The
substrate appears to be docked between stems II and VI, in
a cleft formed by the three-way junction involving stems II,
III and VI, where it makes close interactions with the
internal loop of stem VI (Fig. 7b). An adenosine (A756) in
this highly conserved internal loop and a guanosine (G638)
Fig. 6 Various modulations of the activity of the hairpin ribozyme.
The inactive and active states are indicated by ‘‘off’’ and ‘‘on’’,
respectively. The substrate is shown in green, and the portion of the
ribozyme responsible for the modulation in blue. a The adenosine-
dependant hairpin ribozyme [127]. b The FMN aptamer attached by a
communication module [128]. c The SOFA module [62]. BL and BS
indicate blocker and biosensor, respectively. d The oligonucleotide
modulation [129]. The trans-acting oligonucleotide is represented by
the dotted line
Folding of small ribozymes 3945in the internal loop of the substrate have been shown to be
important for catalysis and are probably directly implicated
in the chemical reaction, leading to the hypothesis that
these internal loops are in fact the ribozyme’s active site
[133]. The cleavage occurs in the internal loop of stem I
through a general acid–base catalyzed transesteriﬁcation
mechanism. This cleavage has been shown to be a conse-
quence of a one nucleotide shift in the stable secondary
structure of stem I [134], a secondary structure rearrange-
ment that is stabilized by the formation of a kissing loop
pseudoknot interaction. This pseudoknot is composed of
three base pairs formed between the loops of stems I and V,
and is required for the cleavage by VS ribozyme [135].
Hydroxyl radical footprinting showed that a solvent-inac-
cessible core is rapidly formed in this region [136]; the
absence of water is supported by a previous kinetic study
that reported pH variation has only a small effect on this
catalytic RNA [137]. The folding of the VS ribozyme is
ion-induced, and the presence of divalent ions is required,
while the presence of monovalent ions further enhances the
reaction rate [137].
While screening a collection of antibiotics looking for
inhibitors of the VS ribozyme, a class of simple cyclic
peptides was found to enhance ribozyme cleavage [138].
The presence of tuberactinomycin antibiotics and, espe-
cially, viomycin, in a trans-cleavage experiment results in
a more extensive reaction and a decrease in the magnesium
requirements for VS ribozyme cleavage. These antibiotics
are able to interact with RNA and, in the case of the VS
ribozyme, to restore the activity of some mutants, although
the exact mechanism is not known.
Finally, a longer version of the natural VS ribozyme has
a non-essential stem (called stem VII) that increases the
stabilization between the 30 end of the ribozyme and the 50
end of its substrate (Fig. 7a). This version is particularly
interesting in ligation assays since it permits substrate
binding through a secondary structure [139].
GlmS ribozyme
The trans-acting version of the glmS ribozyme is around
120 nucleotides long and is composed of eight small
stems, two of which are pseudoknots (Fig. 8a). The
available crystal structures have shown that coaxial
stacking of RNA helices deﬁnes the global tertiary struc-
ture of the glmS ribozyme, while the catalytic core is
formed by an internal loop involved in the two pseudo-
knots (Fig. 8b) [140, 141]. The double pseudoknot
catalytic core forms a rigid binding pocket that is able
to recognize and use a variety of small hydroxylamines,
such as ethanolamine or tris-hydroxymehylaminomethane,
although only binding of glucosamine results in efﬁcient
cleavage [142]. The glmS ribozyme does not appear to
undergo important conformational changes upon the
binding of its cofactor glucosamine-6-phosphate (GlcN6P).
When the cofactor GlcN6P is bound in the catalytic site
through the recognition of the sugar moiety and of the
phosphate [143], 80% of the solvent-accessible surface of
the metabolite is buried, and the primary amine is well
positioned for catalysis, either directly as a general acid, or
as a general base through water molecules [140]. Metal
ions are required for the formation of the precleavage
structure, but do not appear to play any catalytic roles in
glmS ribozyme activity [143].
Even if glmS ribozyme activity does not rely on con-
formational changes, its unique metabolite dependence
implies an extremely interesting and as yet poorly under-
stood folding pathway. The binding site for the GlcN6P
metabolite is formed through a complex network of inter-
actions that provides sufﬁcient rigidity to the pocket so
that it stays open, with the functional groups ready to
Fig. 7 Structure of the VS ribozyme. The ribozyme and substrate are
denoted by Rz and S, respectively. The cleavage site is indicated by an
arrow. a Secondary structure of a trans-acting version of the VS
ribozyme according to the notation of Leontis and Westhof [145]. A
shortened version can be obtained by removing the non-essential
shaded region at the bottom. The tertiary interactions forming the
kissing loop between loops I and V are illustrated by the thin curved
lines. The dotted line represents the junction that has been removed in
order to generate a trans-acting version. b Structure of the VS
ribozyme obtained by SAXS [131]. The colors of the various domains
are the same in panels A and B
3946 C. Reymond et al.accommodate the cofactor, quite a different scenario from
the induced ﬁt folding usually seen upon substrate binding
with other RNA enzymes. Most of the research to date has
focused on understanding the cleavage reaction, but very
little is known about the folding steps leading to the
cofactor-free structure. This ribozyme has only recently
been discovered, and already some progress has been made
toward the elucidation of its folding pathway. In addition,
both the structural and functional versatility of this ribo-
zyme has been examined by in vitro selection [144].
Concluding remarks
Studies on the natural small ribozymes have made key
contributions to our understanding of the folding of RNA
molecules, and have helped to identify structural features
important for the formation of catalytically active struc-
tures. Although the accurate prediction of the secondary and
tertiary structures of long RNA species is not yet possible,
the current knowledge obtained from these small ribozymes
has considerably improved our view of the folding path-
ways of RNA molecules in general in addition to providing
opportunities for the development of a substantial number
of methodologies for their study. Moreover, the discovery
of other small, natural, self-catalytic ribozymes and ribos-
witches will widen the repertoire of this class of catalytic
ribozyme and will most likely increase our ability to cor-
rectly predict their folding. The characterization of the
interactions involved, combined with the various compo-
nents modulating ribozyme activity, has paved the way for
many developments in the area of the nanotechnology.
Progress in comprehending how the various RNA motifs
interplay together in order to control activity should lead to
a better understanding of complex biological mechanisms
such as the regulation of translation involving several RNA
motifs that form the 50 untranslated region of mRNA. From
this point of view, RNA molecules can be considered as
combinations of building blocks. The designing of complex
ribozymes with several motifs modulating either together,
or sequentially, the catalytic activity is expected to propel
further progress in this direction.
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